Mechanism | AMR genes | Group | No. (%) | Source | Resistance pattern |
---|---|---|---|---|---|
Amber class A β-lactamases | blaTEM.1D_1 | TEM | 3 (3.5%) | Human | PIP-PIT/CTX-CAZ-CAA-CTA-CEP /IMP-MER-ERT |
blaCARB.5_1 | CARB-5 | 3 (3.5%) | Human | ||
Amber class C β-lactamases | blaADC.25_1 | ADC | 14 (16.5%) | Human | 11 [PIP-PIT/CTX-CAZ-CTA-CEP/IMP-MER-ERT] |
71 (83.5%) | Milk powder | 66 [CTX], 10 [ERT] | |||
Amber class D β-lactamases | blaOXA.23_1 | OXA-23 | 12 (14%) | Human | 12 [PIP-PIT/CTX-CAZ-CTA-CE/IMP-MER-ERT], 10 [CAA] |
blaOXA.120_1 | OXA-51 | 2 (2.3%) | Milk powder | CTX | |
blaOXA.203_1 | 1 (1.2%) | Milk powder | CTX | ||
blaOXA.259_1 | 1 (1.2%) | Milk powder | CTX-ERT | ||
blaOXA.343_1 | 4 (4.7%) | Milk powder | – | ||
blaOXA.346_1 | 4 (4.7%) | Milk powder | 4 [CTX], 2 [ERT] | ||
blaOXA.380_1 | 2 (2.3%) | Milk powder | CTX | ||
blaOXA.386_1 | 1 (1.2%) | Milk powder | CTX | ||
blaOXA.424_1 | 1 (1.2%) | Milk powder | CTX-ERT | ||
blaOXA.430_1 | 24 (28.2%) | Milk powder | 24 [CTX], 4 [ERT] | ||
blaOXA.431_1 | 1 (1.2%) | Milk powder | CTX | ||
blaOXA.51_1 | 1 (1.2%) | Milk powder | CTX | ||
blaOXA.64_1 | 9 (10.5%) | Milk powder | 8[CTX]/1 [COL] | ||
blaOXA.66_1 | 10 (11.8%) | Human | 10 [PIP-PIT/CTX-CAZ-CTA/IMP-MER-ERT], 9 [CEP], 7 [CAA]. | ||
blaOXA.69_1 | 1 (1.2%) | Human | PIP-PIT/CTX-CAZ-CAA-CTA-CEP /IMP-MER-ERT | ||
blaOXA.72_1 | 1 (1.2%) | Human | PIP-PIT/CTX-CAZ-CTA/IMP-MER-ERT | ||
blaOXA.91_1 | 2 (2.2%) | Human | PIP-PIT/CTX-CAZ-CAA-CTA-CEP /IMP-MER-ERT | ||
19 (22.3%) | Milk powder | CTX | |||
blaOXA.510_1 | single variant | 1 (1.2%) | Milk powder | CTX | |
blaOXA.521_1 | single variant | 1 (1.2%) | Human | PIP-PIT/CTX-CAZ-CAA-CTA-CEP/IMP-MER-ERT |